Cargando…
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways
ABSTRACT: Keloid disease is characterized by hyperproliferation of responsive fibroblasts with vigorously continuous synthesis of extracellular matrix (ECM) components. Although the process by which keloids develop is poorly understood, most theories of the etiology are referred to fibroblast dysfun...
Autores principales: | Wang, Wenbo, Qu, Miao, Xu, Lan, Wu, Xiaoli, Gao, Zhen, Gu, Tingyu, Zhang, Wenjie, Ding, Xiaoyan, Liu, Wei, Chen, Yue-Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052317/ https://www.ncbi.nlm.nih.gov/pubmed/27339758 http://dx.doi.org/10.1007/s00109-016-1430-3 |
Ejemplares similares
-
Ginsenoside Rg3 inhibits keloid fibroblast proliferation, angiogenesis and collagen synthesis in vitro via the TGF-β/Smad and ERK signaling pathways
por: Tang, Mengyao, et al.
Publicado: (2018) -
Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway
por: Ma, Hui, et al.
Publicado: (2022) -
Melatonin influences the biological characteristics of keloid fibroblasts through the Erk and Smad signalling pathways
por: Huang, Shaobin, et al.
Publicado: (2023) -
TGF-Beta Induced Erk Phosphorylation of Smad Linker Region Regulates Smad Signaling
por: Hough, Chris, et al.
Publicado: (2012) -
STAT3 selectively interacts with Smad3 to antagonize TGF-β signaling
por: Wang, Gaohang, et al.
Publicado: (2015)